- Home
- GTBP vs SILO Comparison
GTBP vs SILO Comparison
Compare GTBP & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- SILO
- Stock Information
- Founded
- GTBP 1965
- SILO 2010
- Country
- GTBP United States
- SILO United States
- Employees
- GTBP N/A
- SILO N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- SILO Apparel
- Sector
- GTBP Health Care
- SILO Consumer Discretionary
- Exchange
- GTBP Nasdaq
- SILO Nasdaq
- Market Cap
- GTBP 6.6M
- SILO 5.9M
- IPO Year
- GTBP N/A
- SILO N/A
- Fundamental
- Price
- GTBP $2.91
- SILO $1.13
- Analyst Decision
- GTBP
- SILO
- Analyst Count
- GTBP 0
- SILO 0
- Target Price
- GTBP N/A
- SILO N/A
- AVG Volume (30 Days)
- GTBP 28.9K
- SILO 150.8K
- Earning Date
- GTBP 11-14-2024
- SILO 11-12-2024
- Dividend Yield
- GTBP N/A
- SILO N/A
- EPS Growth
- GTBP N/A
- SILO N/A
- EPS
- GTBP N/A
- SILO N/A
- Revenue
- GTBP N/A
- SILO $72,102.00
- Revenue This Year
- GTBP N/A
- SILO $1.86
- Revenue Next Year
- GTBP N/A
- SILO N/A
- P/E Ratio
- GTBP N/A
- SILO N/A
- Revenue Growth
- GTBP N/A
- SILO N/A
- 52 Week Low
- GTBP $1.92
- SILO $0.84
- 52 Week High
- GTBP $10.66
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- GTBP 55.53
- SILO 47.77
- Support Level
- GTBP $2.94
- SILO $1.05
- Resistance Level
- GTBP $3.54
- SILO $1.35
- Average True Range (ATR)
- GTBP 0.27
- SILO 0.12
- MACD
- GTBP -0.02
- SILO -0.00
- Stochastic Oscillator
- GTBP 23.05
- SILO 37.14
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.